The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review
-
- Giuseppe Scaletta
- Department of Obstetrics and Gynaecology, Campus Bio-Medico University of Rome, Rome, Italy
-
- Daniela Luvero
- Department of Obstetrics and Gynaecology, Campus Bio-Medico University of Rome, Rome, Italy
-
- Francesco Plotti
- Department of Obstetrics and Gynaecology, Campus Bio-Medico University of Rome, Rome, Italy
-
- Stella Capriglione
- Department of Obstetrics and Gynaecology, Campus Bio-Medico University of Rome, Rome, Italy
-
- Salvatore Lopez
- Department of Obstetrics and Gynaecology, Campus Bio-Medico University of Rome, Rome, Italy
-
- Andrea Miranda
- Department of Obstetrics and Gynaecology, Campus Bio-Medico University of Rome, Rome, Italy
-
- Corrado Terranova
- Department of Obstetrics and Gynaecology, Campus Bio-Medico University of Rome, Rome, Italy
-
- Roberto Montera
- Department of Obstetrics and Gynaecology, Campus Bio-Medico University of Rome, Rome, Italy
-
- Carlo De Cicco Nardone
- Department of Obstetrics and Gynaecology, Campus Bio-Medico University of Rome, Rome, Italy
-
- Roberto Angioli
- Department of Obstetrics and Gynaecology, Campus Bio-Medico University of Rome, Rome, Italy
書誌事項
- 公開日
- 2017-08-03
- DOI
-
- 10.1080/14737140.2017.1360138
- 公開者
- Informa UK Limited
この論文をさがす
収録刊行物
-
- Expert Review of Anticancer Therapy
-
Expert Review of Anticancer Therapy 17 (9), 827-839, 2017-08-03
Informa UK Limited
